SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

FEINBERG LARRY N

(Last)

(First)

(Middle)

200 GREENWICH AVENUE

3RD FLOOR

(Street)

GREENWICH, CONNECTICUT

06830

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/02/2006

3. Issuer Name and Ticker or Trading Symbol
Oracle Healthcare Acquisition Corp. [ NONE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,250,000⁽¹⁾	I	See footnote⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrants	⁽²⁾	⁽³⁾	Common Stock	416,667	$6	D

Explanation of Responses:

1. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), Mr. Feinberg may be deemed the beneficial owner of 937,500 shares of common stock and 1,312,500 shares of common stock held as of the date herehof by LNF OHAC LLC and Oracle Healthcare Holding LLC, respectively. LNF OHAC LLC and Oracle Healthcare Holding LLC are managed by Mr. Feinberg, as the managing member. Mr. Feinberg disclaims any beneficial ownership of any of the issuer's securities to which this report relates for purposes of Section 16, except to the extent of Mr. Feinberg's indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Feinberg is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

2. The warrants become exercisable upon the later of the issuer's initial business combination or March 2, 2007.

3. The warrants expire on March 2, 2010, or earlier upon redemption.

Remarks:

(4) A Power of Attorney for Mr. Feinberg is being filed with this Form 3 as Exhibit 24.1.

	/s/ Larry N. Feinberg	03/02/2006
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.